NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B
Estimated value
—
Awarded value
—
Suppliers
25
Lots
18
Published
04 Jul 2022
Total lots
18
Awarded
0
Estimated total
£18
Awarded total
—
Lot 18 - Fresh Frozen Plasma
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 16 - Prothrombin Complex dried
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 15 - Fibrinogen Concentrate
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 14 - Von willebrands factor - Recombinant
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 17 - Protein C Concentrate
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 10 - Factor XIII - Plasma Derived
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 11 - Factor XIII - Recombinant
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 9 - Factor X
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 8 - Factor IX - High Purity Factor IX
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 7 - Factor VIII Inhibitor Bypassing Fraction
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 13 - Von willebrands factor - Plasma Derived
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 12 - Factor VIII/ von willebrands factor
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 6 - Porcine Factor VIII - susoctocog alfa
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 5 - Recombinant Factor VII
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 4 - rFIX - Standard Half Life
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 3 - nonacog beta pegol (rFIX EHL)
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 2 - albutrepenonacog alfa (rFIX EHL)
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV
Lot 1 - eftrenonacog alfa (rFIX EHL)
Start
30 Jun 2022
End
30 Jun 2024
Estimated
£1
CPV